Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
BIO-key Regains Compliance with Nasdaq Listing Rules; Nasdaq Trading Resumes on Wednesday, July 8th
-
Central Asia Accelerates Digital Transformation as "Digital Silk Road" Drives Development Momentum
-
Clearmind Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration Development for MEAI
-
Heidmar Maritime Holdings Corp. Expands Ship Management Platform
-
Heidmar Maritime Holdings Corp. Expands Ship Management Platform
-
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
-
Falco Announces Early Warrant Exercise by Osisko Development Corp. and Additional Warrant Exercises Totaling Approximately $1.25 million
-
Cornerstone First Mortgage Switches to nCino's Mortgage Point of Sale to Support Its Next Phase of Growth
-
Cytokinetics Announces Three Late-Breaking Science Abstracts at the European Society of Cardiology (ESC) Congress 2026
-
Glass House Brands Completes First International Hemp Sale
-
South Plains Financial, Inc. Announces Second Quarter 2026 Earnings Call
-
ZenaTech’s ZenaDrone Advances Defense Drone Portfolio with Initial IQ Sphere Prototype for Autonomous GPS-Denied Inspections, Surveillance and Reconnaissance Missions
-
Streamex Corp. Announces 10,000,000 Share Repurchase Program
-
MeiraGTx Announces $400 million Strategic Investment by Oberland Capital to Support Development and Commercialization of AAV2-hAQP1 and Botaretigene Sparoparvovec (bota-vec)
-
BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™
-
Cornerstone First Mortgage Switches to nCino's Mortgage Point of Sale to Support Its Next Phase of Growth
-
Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 202
-
Bread Financial Schedules Second Quarter 2026 Earnings Conference Call for Jul. 23
-
Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential
-
AI Takes Center Stage at Blockchain Futurist Conference 2026
-
ExperienceMINT™ Launches ELEVATE™ – Bringing Intelligent Experiences to Retail that Increase Conversion by 25%-50% and Reduce Returns by 50%
-
Alterity Therapeutics Receives FDA End-of-Phase 2 Meeting Minutes Confirming Registrational Pathway for ATH434 in Multiple System Atrophy
-
Gilat Receives $11 Million in U.S. Department of War Orders, Reinforcing Role in Mission-Critical Defense Connectivity
-
Stallion Uranium Defines Priority Target Areas from VTEM Survey on Stone Island Target, Moonlite Project
-
Vema Hydrogen and SAF+ International Group Partner to Produce Synthetic Sustainable Aviation Fuel for Canada’s Aviation Industry
-
WRAP Launches WrapShield: An Autonomous Defense & Public Safety Platform, Beginning with Advanced Thermal Polarimetric Sensing for Counter-UAS and Expanding Across AI-Enabled Security Responses
-
Dundee Corporation Announces the Start of Exploration at Westhaven’s Spences Bridge Gold Belt Properties, Southern British Columbia
-
Alfred University and Classiq Launch Quantum Computing Initiative
-
U.S. FDA Grants Priority Review to Agios’ sNDA for Mitapivat in Sickle Cell Disease
-
Kymera Therapeutics Appoints Elizabeth Laws, Ph.D., as Senior Vice President, Global Program Team Leader for KT-621, First-in-Class, Oral STAT6 Degrader
-
Westhaven Announces the Start of Exploration at the Spences Bridge Gold Belt Properties, Southern British Columbia
-
Aclarion Announces Texas Spine Care Center as New CLARITY Site
-
Fredonia Provides El Dorado Monserrat Project and Corporate Update
-
Miata Makes Significant New Discovery at Puma with 17.19 m at 3.14 g/t Au, and 21.64 m at 1.70 g/t Au
-
Aben Gold Provides Update on 2026 Drill Program at the Justin Gold-Tungsten Project
-
Aquestive Therapeutics to Participate in Leerink Partners Therapeutics Forum: I&I and Metabolism
-
MariMed’s Nature’s Heritage Launches “The Nose Knows” Immersive, Science-Backed Consumer Education Campaign
-
Tvardi Therapeutics’ TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement
-
American Lithium Highlights Renewed Momentum for Peru’s Mining Sector Following Keiko Fujimori’s Presidential Election Victory
-
VR completes 2,900 ft hole and polyphase vein intersection at its New Boston Moly-Tungsten-Copper-Silver Porphyry Project in Nevada; core scanning and continuous geochemistry are underway
-
Plug Wins 50MW Electrolyzer Order as Orica's Hunter Valley Hub Becomes the Largest Australian Renewable Hydrogen Project to Reach FID
-
Kailera Therapeutics Announces Positive Topline Data from Two Hengrui Pharma Phase 3 Clinical Trials of Oral Small Molecule GLP-1 Receptor Agonist HRS-7535/KAI-7535
-
OKYO Pharma to Participate in a Fireside Chat at Piper Sandler 2026 Virtual Ophthalmology Symposium
-
Crypto News Today: Pepeto Staking Pays 169% APY While Solana Price Targets $600
-
Troilus Drills 164 m Grading 0.95 g/t AuEq While Testing Unsampled Historic Drillhole Intervals in the Z87 Reserve Pit
-
WRAP Launches WrapShield: An Autonomous Defense & Public Safety Platform, Beginning with Advanced Thermal Polarimetric Sensing for Counter-UAS and Expanding Across AI-Enabled Security Responses
-
Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease
-
Aeluma CEO to Chair Optica Advanced Photonics Congress Industry Program on AI and Quantum
-
Axsome Therapeutics Initiates FOCUS-2 Phase 3 Trial of Solriamfetol in Children with Attention Deficit Hyperactivity Disorder (ADHD)
-
Plug Wins 50MW Electrolyzer Order as Orica's Hunter Valley Hub Becomes the Largest Australian Renewable Hydrogen Project to Reach FID
